No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 27; no. 4; pp. 653 - 655
• Main Authors: Nomoto, Hidetoshi, Kutsuna, Satoshi, Okuma, Kazu, Kuramitsu, Madoka, Tezuka, Kenta, Ikebe, Emi, Saito, Sho, Kinoshita, Noriko, Terada, Mari, Endo, Mio, Suzuki, Tetsuya, Miyazato, Yusuke, Nakamoto, Takato, Inada, Makoto, Hamaguchi, Isao, Ohmagari, Norio
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.04.2021; Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd
• Subjects: Adult; Aged; Convalescent plasma; Coronavirus 2019; COVID-19 - blood; COVID-19 - therapy; Female; Humans; Immunization, Passive; Male; Middle Aged; Passive immunization; RNA; RNA, Viral - blood; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Severity of Illness Index; FDA; RNA; CPT; Coronavirus 2019; Convalescent plasma; Severe acute respiratory syndrome coronavirus 2; COVID-19; NIID; SARS-CoV-2; SNS; JRC; Passive immunization; NCGM

Convalescent plasma transfusion (CPT), a potential therapy for coronavirus disease 2019 (COVID-19), requires strict quality control of the donor blood. Whether to confirm the disappearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA (RNAemia) in convalescent donor blood or no...